PTX3 and coronary artery disorder: Although pentraxin-3 levels were generally higher in the S-CCS group, the variation was modest and nonsignificant, aligning with meta-analyses that report stronger associations of pentraxin-3 with acute coronary syndromes rather than stable CAD.